CLYM
Climb Bio
CLYM
CLYM
80 hedge funds and large institutions have $100M invested in Climb Bio in 2024 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 28 increasing their positions, 12 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
64% less capital invested
Capital invested by funds: $278M → $100M (-$178M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
80
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.83M | |
| 2 | +$1.17M | |
| 3 | +$985K | |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
+$837K |
| 5 |
BlackRock
New York
|
+$790K |
Top Sellers
| 1 | -$3.12M | |
| 2 | -$3.01M | |
| 3 | -$2.03M | |
| 4 |
AAA
Affinity Asset Advisors
New York
|
-$1.8M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$1.26M |